TruTrace Technologies (CSE:TTT, OTC:BKKSF) was recently featured in an article by Coindesk regarding the company’s new partnership with TheraCann.
TruTrace Technologies (CSE:TTT, OTC:BKKSF) was recently featured in an article by Coindesk regarding the company’s new partnership with TheraCann, an international cannabis consultancy and technology company. The Panamanian company is interested in adding forensic traceability to the cannabis industry through TruTrace’s industry blockchain hub. Under the terms of the agreement, TruTrace and TheraCann are expected to explore opportunities to combine TruTrace’s StrainSecure™ technology with Theracann’s ETCH biotrace™ genetic tracking system for cannabis and hemp.
“Creating an eco-system of technologies with the intent to provide patients, government, and the industry with supply chain integrity, true IP protection and analytical testing and validation is an important next step for the cannabis and hemp industry evolution,” said Robert Galarza, CEO of TruTrace Technologies. “We are excited to connect Theracann’s ETCH molecular track and trace system with StrainSecure and to explore additional opportunities for collaboration between our organizations.”
TruTrace is working to establish partnerships with industry leaders and complementary technology companies. The company has recently announced a pilot program with Canada’s largest pharmacy chain, Shoppers Drug Mart, to develop a central hub for identifying, tracking and validating products.
To read the full article from Coindesk, click here.